BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025
• 2026

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November
• December

Day

• 1
• 2
• 3
• 4
• 5
• 6
• 7
• 8
• 9
• 10
• 11
• 12
• 13
• 14
• 15
• 16
• 17
• 18
• 19
• 20
• 21
• 22
• 23
• 24
• 25
• 26
• 27
• 28
• 29
• 30
• 31

• Genetown

  Dianthus Therapeutics Launches with $100M to Develop Selective Antibody Complement Therapeutics to Treat Severe and Rare Autoimmune Diseases

  Dianthus Therapeutics, a biotechnology company dedicated to advancing the next generation of antibody complement therapeutics, today announced the completion of its $100 million Series A financing.

  May 3, 2022

   · 

  5 min read
• Lutris Pharma to Present at the Bio€quity Europe Conference

  Lutris Pharma today announced that Benjamin W. Corn , MD, PhD, Chief Medical Officer, will present a company overview at the Bio€quity Europe 2022 conference taking place in Milan, Italy May 17-18, 2022.

  May 3, 2022

   · 

  1 min read
• BioCapital

  REGENXBIO Announces Presentations at the American Society of Gene & Cell Therapy (ASGCT) 25th Annual Meeting

  REGENXBIO Inc. (Nasdaq: RGNX) today announced presentations at the American Society of Gene & Cell Therapy (ASGCT) 25th Annual Meeting, taking place virtually and in Washington, D.C. from May 16 through 19, 2022.

  May 3, 2022

   · 

  5 min read
• Business

  Teva Reports First Quarter 2022 Financial Results

  Teva Pharmaceutical Industries Ltd. (NYSE and TASE: TEVA) today reported results for the quarter ended March 31, 2022.

  May 3, 2022

   · 

  41 min read
• Business

  908 Devices Partners with Key Biomanufacturing Innovation Center

  908 Devices is partnering with the Advanced Mammalian Biomanufacturing Innovation Center (AMBIC), an academic-industry research consortium dedicated to implementing bioengineering innovations that enhance the development and manufacture of complex biotherapeutics.

  May 3, 2022

   · 

  5 min read
• Business

  Catalent, Inc. Reports Third Quarter Fiscal 2022 Results

  Catalent, Inc. today announced financial results for the third quarter of fiscal 2022, which ended March 31, 2022.

  May 3, 2022

   · 

  26 min read
• Genetown

  Aura Biosciences to Present at the 2022 Bank of America Healthcare Conference

  Aura Biosciences Inc. today announced that Elisabet de los Pinos, PhD, Chief Executive Officer of Aura will present at the 2022 Bank of America Healthcare Conference.

  May 3, 2022

   · 

  2 min read
• Business

  Epizyme Announces Date of First Quarter 2022 Financial Results

  Epizyme today announced that management will host a conference call to discuss its first quarter 2022 financial results and provide a business update on Tuesday, May 10, 2022 at 8:30 a.m. ET.

  May 3, 2022

   · 

  1 min read
• Business

  Incyte Reports 2022 First Quarter Financial Results and Provides Updates on Key Clinical Programs

  Incyte (Nasdaq:INCY) today reports 2022 first quarter financial results, and provides a status update on the Company’s clinical development portfolio.

  May 3, 2022

   · 

  29 min read
• Drug Development

  AVROBIO to Present New Clinical and Preclinical Data at the ASGCT 25th Annual Meeting

  AVROBIO to Present New Clinical and Preclinical Data at the ASGCT 25th Annual Meeting.

  May 3, 2022

   · 

  5 min read